We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

From Batch to Continuous Flow Processing: Development of Safe and Improved Methods for Aerobic Oxidation

Video   Jun 09, 2015

 



About the Speaker
Dr. Alain Favre-Réguillon graduated in 1996 from University of Lyon with a PhD in organic chemistry on extraction of radioactive caesium using functionalized crown-ethers and calixarenes. Subsequently, he joined the Department of Chemistry at Conservatoire National des Arts et Métiers (Paris) as associate professor. He develops new ligand platforms for MRI contrast agents. In 2001 he moved back to University of Lyon at the Institute for Molecular and Supramolecular Chemistry and Biochemistry (ICBMS) in the team of Pr. Marc Lemaire. Research activities at ICBMS focus on sustainable chemistry, atom economical strategies and catalytic processes. In 2011 he joined the Laboratoire de Génie des Réacteurs Catalytique (LGPC) headed by Dr. Claude de Bellefon. His research interests now lie in use of advanced flow reactors for mass or heat transfer demanding reactions and lignocellulosic biomass valorisation.Abstract
This talk will highlight the advantages of continuous flow gas-liquid processes for aerobic oxidation of aldehydes and alcohols. The simple experimental setup in combination with the benefits given by continuous flow technology, including safety, renders the procedure synthetically very interesting and we will show that high throughput screening of experimental conditions resulted in the development of improved protocols.

 
 
 
Advertisement
 

Recommended Videos

How Fast Can a Vaccine Be Made?

Video

When a new pathogen emerges, our bodies and healthcare systems are left vulnerable. And when this pathogen causes the outbreak of a pandemic, there’s an urgent need for a vaccine to create widespread immunity with minimal loss of life. So how quickly can we develop vaccines when we need them most?

WATCH NOW

TSE Explores Drug Discovery – Testing a Drug Compound: Clinical Trials

Video

In this episode we speak with Dr Stephen Wright, Consultant in Medicines Development from Limber Strategic, who talks to us about the clinical development of a drug, including how clinical trials are designed and the role of regulatory authorities in the process.

WATCH NOW

TSE Explores Drug Discovery – Identifying and Optimizing a Promising Drug

Video

In this episode we speak with Professor Paul Brennan from the University of Oxford about lead optimization, what to consider when designing a new drug, and much more.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE